Hemostasis diagnostics help identify the
hemostatic defects that cause excessive bleeding. Hemostasis is a
process of slowing and stopping the blood flow to initiate wound
healing after a vascular injury and is the key procedure acting in
the first line of action adopted by the body. During the process,
blood changes its form from fluid state to gelatinous state.
Hemostasis is maintained in the body via three mechanisms namely
vasoconstriction, platelet plug formation and blood coagulation. The
diagnosis helps predict the cause of excessive bleeding during the
surgery, identifies hemostatic defects in patients with a history of
excessive bleeding. Based on the research articles published by
medical experts, the appropriate therapy to treat hemorrhage can be
administered of fresh frozen plasma for coagulation defects, Von
Willebrand factor concentrates for platelet function defects or
antifibrinolytic agents for systemic fibrinolysis.
Rising prevalence of hemophilia drives the
hemostasis diagnostics market globally
The critical nature of the procedure in the field
of medicine and healthcare has gained prominent position in the
hemostasis diagnostics market. According to the National Hemophilia
Foundation in 2012, the global incidence of hemophilia is
estimated to be 400,000 people. The
rise in the prevalence of genetically inherited disorders such as
hemophilia, increase in number of surgeries and trauma patients,
surge in the usage of recombinant products are the collective factors
driving the global market. The growing technological advances in
molecular diagnostics, inexpensive and biodegradable diagnostic
products, chromogenic substrates, monoclonal antibodies,
immunoassays, laboratory automation is estimated radically change the
Hemostasis diagnostics market over the following five years.
Request a sample copy of this report:
https://www.coherentmarketinsights.com/insight/request-sample/434
The global hemostasis diagnostics market is
segmented on the basis of product type, technology, end user and
geography.
On the basis of product type, the global
market is segmented into:
-
Infusible hemostats
-
Topical hemostats
-
Advanced hemostats
-
Sealants
On the basis of technology, the global
market is segmented into:
-
Optical
-
Electrochemical
-
Mechanical
On the basis of end user, the global
market is segmented into:
-
Hospitals
-
Clinical testing laboratories
-
Research and academic institutes
-
Others
North America is the key growth engine in
the global hemostasis diagnostics market
Regional segmentation of the Hemostasis Diagnostic
Market by Coherent Market Insights comprises North America, Europe,
Asia Pacific, Latin America, Middle East, and Africa. According to
the Centre for Disease Control and Prevention in 2015, the number of
people with hemophilia in the U.S. is estimated to be 20,000. This
positions North America as the most dominant region in the global
hemostasis diagnostics market, owing to the rise in installed
instruments leading to higher sales of reagents and support services.
According to The European National Registry of Congenital
Coagulopathies in 2017, the number of people identified with
hemostasis has increased from 7000 in 2000 to over 11,000 in 2015.
Therefore, European market is expected to grow steadily boosting the
demand for hemostasis diagnostics. Significant growth of markets in
India, China, and Brazil is registering due to rise in health care
expenditure, higher affordability, improving technical capabilities
and economic development. These market are expected to attract global
companies for capitalizing on the hemostasis diagnostics market
opportunities.
Request to view table of content @
https://www.coherentmarketinsights.com/ongoing-insight/toc/434
U.S. Beckman Coulter holds over half the
U.S. market for Hematology devices
Key players operating in the market are HORIBA,
Ltd., Abbott Laboratories, Siemens AG, and Bio-Rad Laboratories,
Inc.The high and low end analyzers provided by U.S. Beckman Coulter
meet the needs of all hematology testing environment. Other vendors
who have adopted ideal product models, business expansion and market
appeal strategies are Becton, Dickinson & Company, Grifols S.A,
Alere, Inc., F. Hoffmann-La Roche AG, Beckman Coulter Inc. Sekisui,
Helena Labor, Chrono-Log, and Axis-Shield.
About Coherent Market Insights:
Coherent Market Insights is a
prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations
related to emerging market trends, technologies, and potential
absolute dollar opportunity
No comments:
Post a Comment